RAYDERM RE-GENERATING CREAM- glycerin cream cream 
VORY MEDICAL. Inc

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

ACTIVE INGREDIENT

Glycerin (25.003%) - Skin Protectact

INACTIVE INGREDIENT

Purified Water, Propanediol, Pentylene Glycol, Caprylic/Capric Triglyceride, Rosehip Fruit Oil, Niacinamide, Black Rice Bran Extract, Butylene Glycol, rh-Polypeptide-1, rh-Oligopeptide-1, rh-Oligopeptide-2, rh-Polypeptide-62, rh-Polypeptide-3, Ceramide NP, Panthenol, Tocopheryl Acetate, Nelumbium Speciosum Flower Extract, Hydrolyzed Hyaluronic Acid, Pseudoalteromonas Fermented Extract, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Cetearyl Olivate, Sorbitan Olivate, Hydrogenated Lecithin, Adenosine, Sodium Hyaluronate, Caprylyl Glycol, 1,2-Hexanediol

PURPOSE

Skin Protectact

WARNINGS

Precautions of Use
1) If rash, redness, swelling, itching or other adverse reactions occur as a result of exposure to sunlight during or after use, consult a doctor / specialist.
2) Refrain from using on wound sites.
3) Storage and handling precautions:
i) Keep out of reach of children.
ii) Keep away from direct sunlight

KEEP OUT OF REACH OF CHILDREN

INDICATIONS & USAGE

Apply the cream on the skin and spread evenly.

DOSAGE & ADMINISTRATION

Apply the cream on the skin and spread evenly.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image description

RAYDERM RE-GENERATING CREAM 
glycerin cream cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72543-002
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
glycerin (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) glycerin12.5 g  in 50 mL
Inactive Ingredients
Ingredient NameStrength
water (UNII: 059QF0KO0R)  
PROPANEDIOL (UNII: 5965N8W85T)  
PENTYLENE GLYCOL (UNII: 50C1307PZG)  
NIACINAMIDE (UNII: 25X51I8RD4)  
ROSA CANINA FRUIT OIL (UNII: CR7307M3QZ)  
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) (UNII: 86FQE96TZ4)  
PANTHENOL (UNII: WV9CM0O67Z)  
CETEARYL OLIVATE (UNII: 58B69Q84JO)  
SORBITAN OLIVATE (UNII: MDL271E3GR)  
CERAMIDE NP (UNII: 4370DF050B)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
NELUMBO NUCIFERA FLOWER (UNII: 61W322NLDV)  
ADENOSINE (UNII: K72T3FS567)  
1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72543-002-0150 mL in 1 PACKAGE; Type 0: Not a Combination Product10/11/2018
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34710/11/2018
Labeler - VORY MEDICAL. Inc (694721104)
Registrant - VORY MEDICAL. Inc (694721104)
Establishment
NameAddressID/FEIBusiness Operations
VORY MEDICAL. Inc694721104manufacture(72543-002)

Revised: 10/2018
Document Id: d971ddea-3495-4203-af43-dde7cdf6f785
Set id: cced3c98-9e73-4036-8e20-688f36d57d99
Version: 1
Effective Time: 20181011
 
VORY MEDICAL. Inc